Aurora Cannabis Inc. (ACB) will probably climb -100 percent over the next 12 months, according to price target estimates compiled by finviz. Meanwhile, they have set a $15price as 12-month high target. This represents a whopping 132.92 percent increase from where shares are trading today. The 12-month median price target assigned by the analysts stands at $10.75, which represents a return potential of 66.93 percent when compared to the closing price of the stock of $6.44 on Friday, January 18. The lowest price target for the stock is $6 — slightly more than -6.83 percent from ACB’s current share price.
The stock is currently hovering around the first support level of $6.15. Below this, the next support is placed in the zone of $5.85. Till the time, the ACB stock trades above this level, bulls have nothing to fear. On momentum oscillators front, ‘RSI’ has touched 56.59 on daily chart, which may remain a cause for concern. If the price breaks below $5.85 level on closing basis, then we may see more profit booking and the stock may show further weakness. On the flipside, hitting the $6.79 mark may result into a pull-back move towards $7.13 level.
On 18th of January, Aurora Cannabis Inc. (NYSE:ACB) shares ended lower after a volatile session. The shares dropped -0.13 points or -1.98 percent at $6.44 with a heavy trade volume of 39.208 million shares. After opening the session at $6.68, the shares went as high as $6.84 and as low as $6.2, the range within which the stock’s price traded throughout the day. The firm is left with a market cap of $6.22 billion and now has 965.11 million shares outstanding. Aurora Cannabis Inc. (ACB) stock has gained 16.46 percent of market value in 21 trading days.
ACB stock has a trailing 3-year beta of 0, offering the possibility of a lower rate of return, but also posing less risk. The portion of a company’s profit allocated to each outstanding share of common stock was $0.22 a share in the trailing twelve months. The stock’s value has surged 29.84 percent year to date (YTD) against a decline of -36.15 percent in 12 month’s time. The company’s shares still trade -48.58 percent away from its 1-year high of $12.52 and 65.13 percent up from 52-week low of $3.90. The average consensus rating on the company is 0, on a scale where 5 equates to a unanimous sell rating. In short, the mean analyst recommendations are calling this stock a buy.
Shares of Aurora Cannabis Inc. (ACB) are trading at a P/E ratio of 30.91 times earnings reported for the past 12 months. The industry ACB operates in has an average P/E of 29.45. Its P/E ratio went as low as 58.71X and as high as 58.71 over the 5-year span. Further, it is sporting a 107.91 on the Price-to-Sales ratio. Compare this with the industry average P/S of 19.89. 0 percent is the gross profit margin for Aurora Cannabis Inc. and operating margin sits at 0 percent. Along with this, the net profit margin is 0 percent.
Let’s take a look at some insider activity at Aurora Cannabis Inc. (NYSE:ACB) and see the pattern.